Contrasting Views of Investors Dominate Closings in Shkreli Trial

Lawyers making closing arguments in the securities fraud trial of ex-pharmaceutical executive Martin Shkreli on Thursday painted contrasting portraits of investors who were allegedly defrauded by the so-called "Pharma Bro."

Expert Analysis

This Week's Summaries

Legal Tweets

Special Reports